Literature DB >> 28875290

Evaluation of [99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice.

Gezim Bala1,2, Henri Baudhuin1, Isabel Remory1,3, Kris Gillis1,2, Pieterjan Debie1, Ahmet Krasniqi1, Tony Lahoutte1,4, Geert Raes5,6, Nick Devoogdt1, Bernard Cosyns1,2, Sophie Hernot7.   

Abstract

PURPOSE: Macrophage accumulation characterizes the development of atherosclerotic plaques, and the presence of certain macrophage subsets might be an indicator of plaque phenotype and (in)stability. The macrophage mannose receptor (MMR) is expressed on alternatively activated macrophages and found at sites of intraplaque hemorrhage and neovascularization. It has been proposed as target to identify vulnerable plaques. Therefore, we aimed to assess the feasibility of using anti-MMR nanobodies (Nbs) as molecular tracers for nuclear imaging in an animal model of atherosclerosis. PROCEDURE: Anti-MMR and control Nb, radiolabeled with Tc-99m, were injected in ApoE-/- and/or C57Bl/6 mice (n = 6). In vivo competition studies involving pre-injection of excess of unlabeled anti-MMR Nb (n = 3) and injection of anti-MMR Nb in MMR-/- mice (n = 3) were performed to demonstrate specificity. At 3 h p.i. radioactive uptake in organs, tissues and aorta segments were evaluated. Autoradiography and immunofluorescence were performed on aortic sections.
RESULTS: Significantly higher uptake was observed in all aortic segments of ApoE-/- mice injected with anti-MMR Nb compared to control Nb (1.36 ± 0.67 vs 0.38 ± 0.13 percent of injected dose per gram (%ID/g), p ≤ 0.001). Surprisingly, high aortic uptake was also observed in C57Bl/6 mice (1.50 ± 0.43%ID/g, p ≥ 0.05 compared to ApoE-/-), while aortic uptake was reduced to background levels in the case of competition and in MMR-/- mice (0.46 ± 0.10 and 0.22 ± 0.06%ID/g, respectively; p ≤ 0.001). Therefore, expression of MMR along healthy aortas was suggested. Autoradiography showed no specific radioactive signal within atherosclerotic plaques, but rather localization of the signal along the aorta, correlating with MMR expression in perivascular tissue as demonstrated by immunofluorescence.
CONCLUSIONS: No significant uptake of MMR-specific Nb could be observed in atherosclerotic lesions of ApoE-/- mice in this study. A specific perivascular signal causing a non-negligible background level was demonstrated. This observation should be considered when using MMR as a target in molecular imaging of atherosclerosis, as well as use of translational animal models with vulnerable plaques.

Entities:  

Keywords:  Atherosclerosis; Macrophage mannose receptor; Molecular imaging; Nanobody

Mesh:

Substances:

Year:  2018        PMID: 28875290     DOI: 10.1007/s11307-017-1117-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  29 in total

Review 1.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

Review 2.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

3.  Distribution of macrophage polarization markers in human atherosclerosis.

Authors:  J Lauran Stöger; Marion J J Gijbels; Saskia van der Velden; Marco Manca; Chris M van der Loos; Erik A L Biessen; Mat J A P Daemen; Esther Lutgens; Menno P J de Winther
Journal:  Atherosclerosis       Date:  2012-09-26       Impact factor: 5.162

Review 4.  Macrophage phenotypes in atherosclerosis.

Authors:  Sophie Colin; Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

5.  Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.

Authors:  Alexis Broisat; Sophie Hernot; Jakub Toczek; Jens De Vos; Laurent M Riou; Sandrine Martin; Mitra Ahmadi; Nicole Thielens; Ulrich Wernery; Vicky Caveliers; Serge Muyldermans; Tony Lahoutte; Daniel Fagret; Catherine Ghezzi; Nick Devoogdt
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

6.  Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

Authors:  J H Lardenoye; D J Delsing; M R de Vries; M M Deckers; H M Princen; L M Havekes; V W van Hinsbergh; J H van Bockel; P H Quax
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

7.  PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.

Authors:  Anneleen Blykers; Steve Schoonooghe; Catarina Xavier; Kevin D'hoe; Damya Laoui; Matthias D'Huyvetter; Ilse Vaneycken; Frederik Cleeren; Guy Bormans; Johannes Heemskerk; Geert Raes; Patrick De Baetselier; Tony Lahoutte; Nick Devoogdt; Jo A Van Ginderachter; Vicky Caveliers
Journal:  J Nucl Med       Date:  2015-06-11       Impact factor: 10.057

8.  SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.

Authors:  Stéphanie Put; Steve Schoonooghe; Nick Devoogdt; Evelien Schurgers; Anneleen Avau; Tania Mitera; Matthias D'Huyvetter; Patrick De Baetselier; Geert Raes; Tony Lahoutte; Patrick Matthys
Journal:  J Nucl Med       Date:  2013-02-27       Impact factor: 10.057

9.  Novel PET Imaging of Atherosclerosis with 68Ga-Labeled NOTA-Neomannosylated Human Serum Albumin.

Authors:  Eung Ju Kim; Sungeun Kim; Hong Seog Seo; Yong Jik Lee; Jae Seon Eo; Jae Min Jeong; Boeun Lee; Jae Young Kim; Young Mi Park; Myeongsook Jeong
Journal:  J Nucl Med       Date:  2016-06-23       Impact factor: 10.057

10.  Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.

Authors:  Gezim Bala; Anneleen Blykers; Catarina Xavier; Benedicte Descamps; Alexis Broisat; Catherine Ghezzi; Daniel Fagret; Guy Van Camp; Vicky Caveliers; Christian Vanhove; Tony Lahoutte; Steven Droogmans; Bernard Cosyns; Nick Devoogdt; Sophie Hernot
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-01-22       Impact factor: 6.875

View more
  9 in total

Review 1.  Imaging Macrophage-associated Inflammation.

Authors:  Catherine A Foss; Julian Sanchez-Bautista; Sanjay K Jain
Journal:  Semin Nucl Med       Date:  2018-02-13       Impact factor: 4.446

2.  An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine- Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker.

Authors:  Zhengyuan Zhou; Nick Devoogdt; Michael R Zalutsky; Ganesan Vaidyanathan
Journal:  Bioconjug Chem       Date:  2018-11-14       Impact factor: 4.774

Review 3.  Re-engineered imaging agent using biomimetic approaches.

Authors:  Tuyen Duong Thanh Nguyen; Ramesh Marasini; Santosh Aryal
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-10-26

Review 4.  Nanobody: a promising toolkit for molecular imaging and disease therapy.

Authors:  Guangfa Bao; Ming Tang; Jun Zhao; Xiaohua Zhu
Journal:  EJNMMI Res       Date:  2021-01-19       Impact factor: 3.138

5.  Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality.

Authors:  Henri Baudhuin; Janik Puttemans; Heleen Hanssens; Philippe Vanwolleghem; Sophie Hernot; Geert Raes; Catarina Xavier; Tony Lahoutte; Pieterjan Debie
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-25

6.  CD93 in macrophages: A novel target for atherosclerotic plaque imaging?

Authors:  Chen Su; Yeming Han; Bin Qu; Chao Zhang; Ting Liang; Feng Gao; Guihua Hou
Journal:  J Cell Mol Med       Date:  2022-02-15       Impact factor: 5.310

Review 7.  Nanobodies as non-invasive imaging tools.

Authors:  M Rashidian; H Ploegh
Journal:  Immunooncol Technol       Date:  2020-07-09

8.  Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.

Authors:  Max L Senders; Sophie Hernot; Giuseppe Carlucci; Jan C van de Voort; Francois Fay; Claudia Calcagno; Jun Tang; Amr Alaarg; Yiming Zhao; Seigo Ishino; Anna Palmisano; Gilles Boeykens; Anu E Meerwaldt; Brenda L Sanchez-Gaytan; Samantha Baxter; Laura Zendman; Mark E Lobatto; Nicolas A Karakatsanis; Philip M Robson; Alexis Broisat; Geert Raes; Jason S Lewis; Sotirios Tsimikas; Thomas Reiner; Zahi A Fayad; Nick Devoogdt; Willem J M Mulder; Carlos Pérez-Medina
Journal:  JACC Cardiovasc Imaging       Date:  2018-10-17

9.  Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells.

Authors:  Bjoern Traenkle; Philipp D Kaiser; Stefania Pezzana; Jennifer Richardson; Marius Gramlich; Teresa R Wagner; Dominik Seyfried; Melissa Weldle; Stefanie Holz; Yana Parfyonova; Stefan Nueske; Armin M Scholz; Anne Zeck; Meike Jakobi; Nicole Schneiderhan-Marra; Martin Schaller; Andreas Maurer; Cécile Gouttefangeas; Manfred Kneilling; Bernd J Pichler; Dominik Sonanini; Ulrich Rothbauer
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.